Assessment of chromium tripicolinate supplementation and dietary energy level and source on growth, carcass, and blood criteria in growing pigs

Two experiments were conducted to evaluate potential interactive effects of supplemental Cr and dietary energy supply in growing pigs. Experiment 1 used 36 individually penned barrows, 25 to 65 kg, in a 2 x 3 factorial arrangement of supplemental Cr (0 or 200 ppb) and energy level (70, 80, or 90% of ME requirement). A corn-soybean meal basal diet was designed to supply all protein, mineral, and vitamin needs and 70% of the estimated ME need at 70% of ad libitum feed intake. Additional energy to 80% or 90% of the ME requirement was provided by a cornstarch/corn oil blend. In Exp. 2, 30 individually penned barrows, 23 to 68 kg, were used in a 2 x 4 factorial arrangement of supplemental Cr (0 or 200 ppb) and added energy source (none, cornstarch, corn oil, or choice white grease) with basal diets identical to Exp. 1. The various energy sources were added to 90% of the ME requirement. In both experiments, growth data were collected over a 50-d period and pigs were killed at 70.1 kg. Increasing energy levels increased (linear, P < 0.01) ADG, average backfat thickness, 10th rib backfat thickness, and cooler shrink and decreased (linear, P < 0.01) longissimus muscle area in Exp. 1. Carcass composition increased (linear, P < 0.01) in lipid and decreased in protein, water, and protein:lipid ratio in response to increasing ME levels. Similar results were observed in Exp. 2 in response to added energy, regardless of the energy source used. In response to ME, linear increases (P < 0.05) in plasma insulin concentration before feeding and after feeding were observed in Exp. 1. In Exp. 2, plasma insulin concentration was lower for the basal diet before feeding (P < 0.05) and higher for the starch diet after feeding (P < 0.01); insulin:glucose ratio increased (P < 0.01) after feeding for starch compared to oil and fat. No consistent effect of Cr or Cr x ME level on performance or carcass was observed (P > 0.10) in these experiments. Similarly, no Cr effect or Cr x ME interaction (P > 0.10) was observed in plasma glucose or insulin levels. Dietary energy levels markedly affected growth criteria in growing pigs (23 to 68 kg) in these experiments, as anticipated, but supplemental Cr was without effect on performance or carcass responses.     

Assessment of chromium tripicolinate supplementation and dietary protein level on growth,carcass, and blood criteria in growing pigs

This study was conducted to evaluate potential interactive effects of supplemental Cr and dietary protein levels in growing pigs. Thirty-six individually penned barrows, 22 to 63 kg, were used in a 2 x 3 factorial arrangement of supplemental Cr (0 or 200 ppb from chromium tripicolinate) and protein level (76, 83, or 90% of lysine requirement). A corn-soybean meal basal diet was designed to supply all mineral and vitamin needs, 90% of the estimated metabolizable energy need, and 76% of the estimated protein need at 70% of ad libitum feed intake. Additional protein to 83 or 90% of the lysine requirement was provided by a soy protein isolate supplement. Growth data were collected for a 50-d period, and pigs were killed at a mean of 63 kg BW. Increasing lysine levels linearly (P < 0.01) increased ADG and liver weight. Lysine level had a quadratic effect on 10th rib backfat thickness (P < 0.05) and cooler shrink (P < 0.01) with the highest responses at the 83% lysine level. Increasing lysine level linearly decreased (P < 0.05) carcass content of ash and lipid and quadratically increased the carcass water content (P < 0.01). Carcass accretion rate showed a linear increase for protein (P < 0.01) and water accretion (P < 0.01). Dry matter composition of the longissimus muscle showed linear increases of ash (P < 0.05) and protein (P < 0.01) and a linear decrease of lipid content (P < 0.01) resulting in a linear increase (P < 0.05) of the protein to lipid ratio based on the increasing lysine levels. Pre-feeding insulin levels were increased (P < 0.05) with increasing level of lysine. One hour post-feeding, a quadratic lysine response for plasma glucose (P < 0.05) was observed with the lowest concentration at 83% lysine. Cr addition increased 10th rib backfat thickness (P < 0.10). There was no Cr x lysine level interaction (P > 0.10) observed for any of the growth or carcass traits. Plasma glucose concentrations pre-feeding were lower for Cr-supplemented pigs (P < 0.01). As expected, increasing protein levels in protein-deficient diets increased protein accretion while decreasing lipid accretion in 22 to 63 kg growing pigs; however, these effects were more clearly seen in the longissimus muscle than in the entire carcass. Supplementation of Cr exerted only minor effects with few Cr x lysine interactions observed in this study.     

Oestrogen-induced bone marrow aplasia in a dog with a Sertoli cell tumour

A 10-year-old male Drahthaar dog with unilateral cryptorchidism was examined because of feminisation and myelotoxicity. Radiography and ultrasonography revealed an abdominal mass which was surgically removed. The mass was identified as a Sertoli cell tumour on histological examination. Findings on bone marrow examination were compatible with aplasia due to the oestrogens secreted by the tumoral cells. Treatment with fluids, antibiotics, whole blood transfusions, corticosteroids and lithium carbonate was unsuccessful. Survival time was 22 days after surgery.     

Explosive increase in Salmonella java in poultry. Consequences for public health

In the Netherlands S. Paratyphi B variation Java increased in poultry from less than 2% of all isolates before 1996 up to 40% in 2001. This development in poultry runs in parallel with that in Germany and appears not to occur in other European countries. A German study shows that in the late nineties it concerns isolates of only one multi-resistant clone of Java (in Holland as well) whilst isolates before the middle nineties were genetically much more heterogeneous and sensitive to antibiotics. Although the exposition of humans to contaminated poultry meat is relatively high, human patients with a Java infection are rare. Treatment of poultry flocks with quinolones was about 13% in 2000-2001. Resistance to flumequin of Java increased from 3% between 1996-1999 to 20% between 2000-2002 whilst that of other serotypes in poultry remained about 7%. Java is also fast becoming less sensitive to ciprofloxacin which is the antibiotic of first choice in serious cases of salmonellosis. The ministries of public health, agriculture and the production boards, with their research institutes, together with the poultry meat production chain integrations have recently decided to work together in order to determine the public health importance of the Java epidemic in poultry and finding measures for effective control in the poultry industry.     

Effectiveness of treatment with lincomycin hydrochloride and/or vaccination against Mycoplasma hyopneumoniae for controlling chronic respiratory disease in a herd of pigs

A herd of pigs infected with Mycoplasma hyopneumoniae was used in a double-blind randomised trial to assess the effectiveness of three control strategies against chronic respiratory disease in growing-finishing pigs. One group of 61 pigs received 220 ppm lincomycin hydrochloride in the feed from day 71 to day 91, a second group was vaccinated against M. hyopneumoniae at four and 28 days of age, and a third group received both treatments; a fourth group was left untreated as a control. Throughout the nursery-finishing period (day 29 to slaughter) the average daily weight gain and feed conversion rate of all the treated groups were slightly better than in the controls, but there were no significant differences between them. There were no significant differences between the treated groups in terms of clinical signs, serology, pathology or mortality, which was very low throughout the trial.     

Pharmacokinetics of phenylbutazone in beef steers

Phenylbutazone was administered intravenously to a group of 11 beef steers at a dosage of 6 mg/kg of body weight. Whole plasma and protein-free plasma were analyzed for phenylbutazone residues. Pharmacokinetic parameters of total and free phenylbutazone in plasma were calculated using a noncompartmental method. In regards to whole plasma data, the mean volume of distribution at steady state (Vss), was 140 mL/kg body weight, with a mean (+/-SEM) terminal elimination half-life (t1/2) of 34 +/- 9 h. The mean clearance was 3.2 mL/h/kg body weight. The Vss, as determined from the protein-free plasma fraction, was 54093 mL/kg body weight. This larger Vss of free phenylbutazone compared with total plasma phenylbutazone was attributed to a high degree of plasma protein binding, as well as the greater penetration of free phenylbutazone into tissues. The mean t1/2 of free phenylbutazone was 35 +/- 12 h. This similarity to the t1/2 estimated from total plasma phenylbutazone data is attributed to an equilibrium between free and plasma phenylbutazone during the terminal elimination phase. The pharmacokinetic parameters of free and total plasma phenylbutazone in beef steers are statistically similar to those previously reported for lactating dairy cows.     

Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhoea virus

Eleven-day-old conventionally reared piglets were inoculated orally with two different doses of the cell-culture adapted strain CV-777 of the porcine epidemic diarrhoea virus (PEDV) or the virulent isolate of the same strain and challenged with the same virulent PEDV 3 weeks later. Pigs inoculated with the two doses of the attenuated virus did not show any typical sign of the disease, and virus shedding was not frequent. In contrast, 31% of pigs exposed to the virulent PEDV developed diarrhoea and virus shedding was demonstrated in 100%. At different postinoculation day (PID) and postchallenge day (PCD) virus-specific antibody-secreting cells (ASC) in gut associated lymphoid tissues (duodenum and ileum lamina propria and mesenteric lymph nodes) and systemic locations (blood and spleen) were assessed by enzyme-linked immunospot (ELISPOT). Only a small response was detected in the groups inoculated with attenuated PEDV, whereas in the group previously exposed to the virulent virus on PID 21 a large number of IgG and IgA ASC was detected. Isotype-specific antibody responses in serum were investigated by ELISA. IgG responses were detected in all groups, although the highest response corresponded to the group inoculated with virulent virus and only this group showed an IgA response. The pigs exposed to virulent PEDV were completely protected against the challenge with a higher dose of the same virulent virus on PID 21 and none of them shed the virus. The pigs inoculated with the attenuated strain were partially protected against the challenge, and 25% of the low dose- and 50% of the high dose-exposed pigs did not shed virus after challenge. All the pigs from a control group, not previously exposed to the virus, excreted the virus in faeces. A strong positive correlation was established between protection and the ASC responses detected in gut associated lymphoid tissues and blood at the challenge day and also between protection and serum isotype-specific antibody titers on that day. In addition, the IgA and IgG ASC responses detected in the blood on PID 21 also correlated with the responses found in the gut associated lymphoid tissues. The ASC and serum antibody responses after the challenge corresponded to a secondary immune response in the groups inoculated with attenuated virus, whereas a primary response was evident in the control group. No increase was seen in any of the parameters studied in the pigs inoculated with virulent PEDV.